Riskpilot← Back to searchSign inGet full accessAggero Medtech AB
ABIn liquidationOrg 5568572167Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20110 employees
Revenue 2021
SEK 0
EBITDA margin
—
+29% vs 2020
Equity ratio
89.7%
Financial strength
Net profit 2021
SEK 104K
+12% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK 138K | +29% |
| Net profit | SEK 104K | +12% |
| Total assets | SEK 406K | +29% |
| Equity | SEK 364K | +40% |
| Employees | 0 | — |
Legal name
Aggero Medtech AB
Org number
5568572167
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
28 juni 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall tillverka och sälja medicinteknisk utrustning samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | 606 | 127 | 21 | 182 | 0 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | — | −7 | 171 | 81 | −127 | 107 | 138 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −7 | 171 | 81 | −127 | 107 | 138 |
| Net financials | — | −3 | — | — | −1 | — | — |
| Profit before tax | 0 | −9 | 146 | 60 | −82 | 98 | 131 |
| Tax | −0 | −0 | −17 | −14 | −0 | −5 | −27 |
| Net profit | 0 | −9 | 129 | 46 | −82 | 93 | 104 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Total assets | 439 | 122 | 293 | 367 | 211 | 314 | 406 |
| Equity | 83 | 73 | 202 | 248 | 167 | 260 | 364 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 356 | 49 | 65 | 73 | 45 | 45 | 27 |
| Total debt | 356 | 49 | 65 | 73 | 45 | 45 | 27 |
EBITDA margin
13800000.0%
This company
15.8%
Market median
+87341672% vs market
20152021
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20152021
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
20152021
Net profit margin
10400000.0%
This company
8.1%
Market median
+128394962% vs market
20152021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152021
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20152021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IE External Signatory | External Signatory | 2021 | — | — |
JL Liquidator | Liquidator | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aggero Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Emma Sofie Nybom | External Signatory | 0 companies |
| Jonny Lennart Greinsmark | Liquidator | 0 companies |
| Curt Anders Bertil Fagergren | Board of Directors | 0 companies |
| Påvel Ingemar Gabriel Lindberg | Deputy Board Member | 0 companies |